- Home
- FCNCA vs IQV Comparison
FCNCA vs IQV Comparison
Compare FCNCA & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCNCA
- IQV
- Stock Information
- Founded
- FCNCA 1898
- IQV 1982
- Country
- FCNCA United States
- IQV United States
- Employees
- FCNCA N/A
- IQV N/A
- Industry
- FCNCA Major Banks
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- FCNCA Finance
- IQV Health Care
- Exchange
- FCNCA Nasdaq
- IQV Nasdaq
- Market Cap
- FCNCA 25.4B
- IQV 27.4B
- IPO Year
- FCNCA N/A
- IQV 2013
- Fundamental
- Price
- FCNCA $2,088.73
- IQV $164.24
- Analyst Decision
- FCNCA Buy
- IQV Buy
- Analyst Count
- FCNCA 10
- IQV 20
- Target Price
- FCNCA $2,348.40
- IQV $226.80
- AVG Volume (30 Days)
- FCNCA 83.6K
- IQV 2.3M
- Earning Date
- FCNCA 07-25-2025
- IQV 07-22-2025
- Dividend Yield
- FCNCA 0.37%
- IQV N/A
- EPS Growth
- FCNCA N/A
- IQV 0.26
- EPS
- FCNCA 175.01
- IQV 7.35
- Revenue
- FCNCA $9,091,000,000.00
- IQV $15,497,000,000.00
- Revenue This Year
- FCNCA N/A
- IQV $5.40
- Revenue Next Year
- FCNCA $2.54
- IQV $5.20
- P/E Ratio
- FCNCA $11.94
- IQV $22.36
- Revenue Growth
- FCNCA N/A
- IQV 2.84
- 52 Week Low
- FCNCA $1,473.62
- IQV $134.65
- 52 Week High
- FCNCA $2,412.93
- IQV $252.88
- Technical
- Relative Strength Index (RSI)
- FCNCA 76.83
- IQV 66.26
- Support Level
- FCNCA $1,952.21
- IQV $155.15
- Resistance Level
- FCNCA $1,946.00
- IQV $167.32
- Average True Range (ATR)
- FCNCA 41.88
- IQV 4.12
- MACD
- FCNCA 23.67
- IQV 0.73
- Stochastic Oscillator
- FCNCA 92.00
- IQV 78.48
About FCNCA First Citizens BancShares Inc.
First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.